Form 4 for IRD Opus Genetics, Inc.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0000905148-25-000712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | 2025-02-13 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | F - Tax | $1.15 | -5,193 | 73.3K | -7% | -$5,972 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | F | D | 5,193 | $1.15 | 73,307 | D | — | — |